Coartem
Active Ingredient(s): Artemether + LumefantrineFDA Approved: * April 7, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Malaria
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Coartem Overview
Artemether/lumefantrine, sold under the trade name Coartem among others, is a combination of the two medications artemether and lumefantrine.[1] It is used to treat malaria caused by Plasmodium falciparum that is not treatable with chloroquine.[1] It is not typically used to prevent malaria.[1] It is taken by mouth.[1] Common side effects include muscle and joint pains, fever, loss of appetite, and headache.[1] Se...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Coartem
Recent Coartem Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Artemether + Lumefantrine
- Tablet: 20mg + 120mg, 20mg/120mg
NDC Database Records for Coartem: (3 results)
Sorted by National Drug Code- 0078-0568 Coartem (Artemether 20 mg / Lumefantrine 120 mg) Oral Tablet by Novartis Pharmaceuticals Corporation
- 55695-020 Coartem Oral Tablet by Department of State Health Services, Pharmacy Branch
- 76413-154 Coartem Oral Tablet by Central Texas Community Health Centers
Drugs with one or more similar ingredients: (3 results)
- ARTEMETHER + LUMEFANTRINE
- ARTEMETHER 1 discussion
- PALUTHER Artemether